Last reviewed · How we verify
QHRD107 capsule,Venclexta and Azacitidine — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
QHRD107 capsule,Venclexta and Azacitidine (QHRD107 capsule,Venclexta and Azacitidine) — Changzhou Qianhong Bio-pharma Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| QHRD107 capsule,Venclexta and Azacitidine TARGET | QHRD107 capsule,Venclexta and Azacitidine | Changzhou Qianhong Bio-pharma Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- QHRD107 capsule,Venclexta and Azacitidine CI watch — RSS
- QHRD107 capsule,Venclexta and Azacitidine CI watch — Atom
- QHRD107 capsule,Venclexta and Azacitidine CI watch — JSON
- QHRD107 capsule,Venclexta and Azacitidine alone — RSS
Cite this brief
Drug Landscape (2026). QHRD107 capsule,Venclexta and Azacitidine — Competitive Intelligence Brief. https://druglandscape.com/ci/qhrd107-capsule-venclexta-and-azacitidine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab